Li Juan Xu (Lijuan Xu)

Years Active: 2020-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Li Juan Xu, Xinyao Zhang, Yin Zhao, Xiaorui Gang, Tao Zhou, Jialing Han, Yang Cao, Binyan Qi, Shuning Song, Xiaojie Wang, Yuan Bo Liang
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals. eLife 12 (2023)
Li Juan Xu, Xinyao Zhang, Yin Zhao, Xiaorui Gang, Tao Zhou, Jialing Han, Yang Cao, Binyan Qi, Shuning Song, Xiaojie Wang, Yuan Bo Liang
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals. eLife 12 (2023)
Li Juan Xu, Xinyao Zhang, Yin Zhao, Xiaorui Gang, Tao Zhou, Jialing Han, Yang Cao, Binyan Qi, Shuning Song, Xiaojie Wang, Yuan Bo Liang
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals. eLife 12 (2023)
Li Juan Xu, Xinyao Zhang, Yin Zhao, Xiaorui Gang, Tao Zhou, Jialing Han, Yang Cao, Binyan Qi, Shuning Song, Xiaojie Wang, Yuan Bo Liang
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals. eLife 12 (2023)
Li Juan Xu, Zhi Gang Lv, Ying Liu, Xiang Xiang Zhang, Yu Xin Cui, Xiao Chun Li, Yi Jun Zhu, Jie He
A novel CRYBB2 mutation causes autosomal dominant cataract: A report from a Chinese family. European journal of ophthalmology 31 (5) (2020)

Li Juan Xu.css-eqlu8i{font-size:small;padding-left:4px;} (Lijuan Xu)